IL5 and COVID-19: 2 weeks after initial infection, the natural course of COVID-19 shows persistent nasal mucosal inflammation with an exaggerated T2 inflammatory response (CCL11 and IL-5) and a sustained pro-inflammatory response (figure 5A-2).